Addressing the Challenges in Rare Disease Methods

Moderator

Matt Griffiths, BA, MSc, Costello Medical, London, United Kingdom

This session highlights multiple areas of challenge in generating robust evidence for value assessment in rare diseases and provides examples of how these challenges play out in varying access contexts (conditional access agreements, joint clinical assessment and national-level HTA).
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×